Manufacturer record
Clevus Lifesciences: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Clevus Lifesciences (Himachal Pradesh) were declared Not of Standard Quality between July 2021 and August 2021. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Clevus Lifesciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Bupropion Hydrochloride Extended Release Tablets USP 150 mg (BUPIDEP-150 ER TABLETS) | CT-12330321Mfg 2021-03 · Exp 2022-08 | DissolutionDissolution | RDTL ChandigarhState lab | Aug 2021 |
| Fexofenadine Tablets I.P. 120 mg | CT-8321220Mfg 2020-12 · Exp 2022-11 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.